Provided by Tiger Trade Technology Pte. Ltd.

Progress

43.13
+3.218.04%
Post-market: 44.601.47+3.41%17:52 EDT
Volume:631.41K
Turnover:27.01M
Market Cap:1.77B
PE:20.83
High:43.96
Open:41.13
Low:40.87
Close:39.92
52wk High:47.37
52wk Low:23.82
Shares:41.01M
Float Shares:40.11M
Volume Ratio:1.62
T/O Rate:1.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.07
EPS(LYR):1.66
ROE:18.57%
ROA:4.89%
PB:3.50
PE(LYR):25.98

Loading ...

Foresight Group Updates Market on Progress of Ongoing Share Buyback Programme

TIPRANKS
·
Sep 11

FSA Group Updates Market on Daily Progress of On-Market Share Buy-Back

TIPRANKS
·
Sep 11

Vita Life Sciences Updates Market on Progress of On-Market Share Buy-Back

TIPRANKS
·
Sep 11

Mirrabooka Updates Investors on Progress of On-Market Share Buy-Back

TIPRANKS
·
Sep 11

AFI Reports Daily Progress in On‑Market Share Buy‑Back

TIPRANKS
·
Sep 11

BrainChip to Brief Investors on Q2 2026 Progress and Edge AI Strategy

TIPRANKS
·
Sep 11

Select Harvests Reports Progress on Ongoing On-Market Share Buy-Back

TIPRANKS
·
Sep 11

Flight Centre Updates Investors on Progress of On-Market Share Buy-Back

TIPRANKS
·
Sep 11

Helia Group Updates ASX on Progress of On-Market Share Buy-Back

TIPRANKS
·
Sep 11

Brambles Updates Market on Progress of Ongoing Share Buy-Back

TIPRANKS
·
Sep 11

Perenti Updates ASX on Progress of On-Market Share Buy-Back

TIPRANKS
·
Sep 11

GeoVax Updates Nasdaq Listing Amid Ongoing Clinical Progress

TIPRANKS
·
Sep 11

SS Innovations Provides Update on Continuing Progress and Milestones

GlobeNewswire
·
Sep 10

Thomas Shrader Reiterates Buy on IRD, Maintains $12 Price Target Amid Encouraging Clinical and Regulatory Progress

TIPRANKS
·
Sep 10

Lead Customer Feedback Marks Progress in Qualification

GlobeNewswire
·
Sep 10

Candel Therapeutics Highlights Progress of Lead Oncology Candidate

TIPRANKS
·
Sep 10

J.Jill Maintained at Hold as Operational Progress Offsets Concerns Over Sustainability and Limited Profit Upside

TIPRANKS
·
Sep 10

Opus Genetics Reach 52-Week High on Clinical Trial, FDA Progress

Dow Jones
·
Sep 10

Boston Scientific’s RESPI Study Signals Progress in Wearable Breathing Monitoring

TIPRANKS
·
Sep 10

Progress Software Unveils Speaker Lineup for Progress Data Platform Summit 2026

Reuters
·
Sep 09